CVRx Inc. (CVRX)
NASDAQ: CVRX
· Real-Time Price · USD
6.58
0.12 (1.86%)
At close: Jun 06, 2025, 3:59 PM
6.56
-0.23%
After-hours: Jun 06, 2025, 04:04 PM EDT
Company Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases.
It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF.
The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally.
CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
CVRx Inc.

Country | United States |
IPO Date | Jun 30, 2021 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 206 |
CEO | Kevin Hykes |
Contact Details
Address: 9201 West Broadway Avenue Minneapolis, Minnesota United States | |
Website | https://www.cvrx.com |
Stock Details
Ticker Symbol | CVRX |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001235912 |
CUSIP Number | 126638105 |
ISIN Number | US1266381052 |
Employer ID | 00-0000000 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Kevin Hykes | President, Chief Executive Officer & Director |
Jared Oasheim | Chief Financial Officer |
Bonnie Handke M.B.A., R.N. | Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics |
Dr. Philip B. Adamson M.D., M.Sc. | Chief Medical Officer |
Jonelle R. Burnham | Vice President & General Counsel |
Paul Pignato | Vice President of Research, Development and Operations |
Paul Verrastro | Chief Marketing & Strategy Officer |
Robert Allen John | Chief Revenue Officer |
Tonya A. Austin SPHR | Chief Human Resources Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jun 05, 2025 | 4 | Filing |
Jun 05, 2025 | 4 | Filing |
Jun 05, 2025 | 4 | Filing |
Jun 05, 2025 | 4 | Filing |
Jun 05, 2025 | 4 | Filing |
Jun 05, 2025 | 4 | Filing |
Jun 05, 2025 | 8-K | Current Report |
May 23, 2025 | SD | Filing |
May 19, 2025 | 4 | Filing |
May 14, 2025 | 4 | Filing |